Controversial Hydroxycut Legal Actions Have Already Been Registered
On May one, 2009, there was a recall of 14 Hydroxycut diet-aid products stemming from a number of reports that people using the products were developing significant liver problems and other health concerns. Less than seven days later, on May four, the first Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Class Action Lawsuit alleges company laxity in informing the public about potential risks of the products. Naturally, it’s too soon to understand the suit is going to turn out, but if the company had information which it did not reveal to customers, it should definitely be held accountable.
A class action lawsuit is filed by a bunch of folks, all of whom have similar claims against a certain company. Filing a class action is just as effective, and a lot less dear, than filing an individual suit. As a rule, filing a class action court action will not cost you anything unless there is a settlement. At that point, the lawyer who handled the suit will take his charges from the compensation that was awarded and then share the leftover funds to the accusers in the case. Since this is the case, you will be able to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the reasons that class action lawsuits have become so popular.
The first class action lawsuit against Iovate was filed in Canada where the company is found and represents all Canadian citizens who sustained health problems due to Hydroxycut products. The FDA recall happened in the U. S. Where twenty-three cases of liver disorders and other health issues had been reported. Health Canada did not receive any reports of liver damage caused by the diet products, but they did receive 17 reports concerning folks who sustained breathing, neurological, cardiovascular, and stomach problems as a result of Canadians using the products.
The Hydroxycut Settlement Suit alleges the company sold the products without correctly informing the general public of the public of the health risks that they could exposing shoppers to. The complaint states the company failed to publish the information on the product labels stating that users could run the risk of liver and kidney damage as well as gut, cardio, respiratory, and neurological problems. The suit goes on to claim this was a blatant omission on the part of the company which purposely misled clients concerning the security of the products.
